How I Manage Patients with Frequent PVCs

Stanford Medicine

R. John

Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?

The Texas Heart Institute

M. Razavi

Postural Tachycardia Syndrome: Pathophysiology and Impact of Tragus …

Virtual EP Connect

V. Reddy, F. Marchlinski, T. Glotzer, B. Olshansky, S. Po, S. Stavrakis

Top 5 Arrhythmias You Need to Know

Joel Gorfinkel

Ischemic Ventricular Tachycardia

Scripps Health

D. Gibson

Brugada Syndrome: What Are the Risk Factors? Can Hyperkalemia Cause …

37th Annual Advances in Heart Disease

M. Scheinman, P. Ganz

The Conquest of Ventricular Tachycardia: Insights into Mechanisms & …

ARCH Advanced Revascularization Symposium

J. M. Miller

Evaluation and Management of Heart Rhythm Disorders in Patients with…

10th Annual California Heart Rhythm Symposium

V. Vedantham

Treatment of HF Beyond CRT: How Effective Are Cardiac Contractility …

Houston Methodist DeBakey Heart and Vascular Center

P. Schurmann

Antiarrhythmic Drugs for AF in the Outpatient Setting

Mayo Clinic Proceedings

C. Desimone

Atrial Fibrillation: Past, Present and Future

Houston Methodist DeBakey Heart and Vascular Center

P. Ellinor

Functional Characterization of VT Substrate Independent from Scar: V…

The Texas Heart Institute

A. D'Avila

Atrial Fibrillation - Current Guidelines and Future Directions

Jefferson Health

R. Borge

Hybrid AFib Ablation: Persistent AFib Management in the Current Era

Nitesh Sood

Is Technology or Physiology the Challenge to Preventing Lethal Arrhy…

Stanford Arrhythmia Symposium

D. Callans

Debate: Role of Digoxin in Heart Failure and Atrial Fibrillation - i…

Cedars Sinai

J. Mandrola

Management of Ventricular Tachycardia

Scripps Health

D. Gibson

AF Ablation as First-Line Therapy: Benefit vs Risk

Virtual EP Connect

V. Reddy, F. Marchlinski, J. Andrade, H. Calkins, V. Fuster, S. Dukkipati

Debate: Should VT Ablation Be the First Line Therapy Before ICD Impl…

10th Annual California Heart Rhythm Symposium

W. Sauer